G I-150 (Ibandronate Sodium 150 mg (base))
Pill with imprint G I-150 is White, Capsule-shape and has been identified as Ibandronate Sodium 150 mg (base). It is supplied by Mylan Pharmaceuticals Inc..
Ibandronate is used in the treatment of prevention of osteoporosis; osteoporosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Ibandronate 150 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).
Images for G I-150
Ibandronate Sodium
- Imprint
- G I-150
- Strength
- 150 mg (base)
- Color
- White
- Size
- 14.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Bisphosphonates
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00378-5215
- Inactive Ingredients
-
ammonia,
ferrosoferric oxide,
silicon dioxide,
crospovidone,
hydroxypropyl cellulose (type h),
lactose monohydrate,
magnesium stearate,
microcrystalline cellulose,
polyethylene glycol,
povidone,
shellac,
titanium dioxide
Note: Inactive ingredients may vary.
Related Images for "G I-150"
More about ibandronate
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 91 Reviews
- Drug class: bisphosphonates
- FDA Alerts (3)
Consumer resources
- Patient Information
- Ibandronate Intravenous (Advanced Reading)
- Ibandronate Oral, Injection (Advanced Reading)
- Ibandronate Tablets
- Ibandronate Injection
- Other brands
- Boniva
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.